QR059349 is a synthetic non-steroidal anti-inflammatory drug belonging to the pyrrolidine-based structural family, primarily utilized for the management of pain, inflammation, and fever. By inhibiting… Read more
QR059349 is a synthetic non-steroidal anti-inflammatory drug belonging to the pyrrolidine-based structural family, primarily utilized for the management of pain, inflammation, and fever. By inhibiting cyclooxygenase enzymes, this compound effectively reduces prostaglandin synthesis. In pharmaceutical research and regulatory testing, access to high-quality reference standards is critical for accurate analytical workflows. This category includes the parent drug alongside its deuterated analogue, QR059349-d6, which functions as a stable isotope labelled standard. These compounds are essential tools for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control assays. By utilizing stable isotope dilution techniques, researchers can achieve precise quantification of the drug and its metabolites in complex matrices, ensuring the reliability of pharmacokinetic studies and overall product integrity during development and manufacturing processes.